Intraoperative adjuncts for malignant pleural mesothelioma

Area of Science:

• Oncology
• Surgical Oncology
• Thoracic Surgery

Background:

• Malignant pleural mesothelioma (MPM) is an aggressive cancer with a poor prognosis.
• Surgical resection is a key component of multimodality therapy for select MPM patients.
• Local recurrence after surgery remains a significant challenge in managing MPM.

Purpose of the Study:

• To review recent advancements in intraoperative adjunctive therapies for MPM.
• To evaluate the efficacy of heated intraoperative chemotherapy (HIOC), heated intraoperative povidone-iodine (PVP-I), and photodynamic therapy (PDT).
• To provide an update on promising strategies to improve local control in MPM.

Main Methods:

• Review of recent clinical studies and trials.
• Focus on intraoperative techniques including HIOC, PVP-I, and PDT.
• Analysis of data related to local recurrence and survival outcomes.

Main Results:

• These novel therapies target micrometastatic disease at the time of surgery.
• HIOC, PVP-I, and PDT aim to enhance local tumor control.
• Emerging data suggests potential benefits in reducing local relapse rates.

Conclusions:

• Intraoperative adjunctive therapies represent a promising frontier in MPM management.
• HIOC, PVP-I, and PDT are under active investigation for improving outcomes.
• Further research is warranted to establish the definitive role of these treatments in MPM.